Jungers P, Dougados M, Gazengel C, Tron F, Bach J F
Ann Med Interne (Paris). 1980;131(7):416-21.
Among 60 patients (56 females, 4 males) with severe forms of SLE, 13 developed thromboembolic arterial and/or venous manifestations, an overall incidence of 21.6 percent. Thrombophlebitis episodes, mainly affecting lower limbs, occurred in 8 patients, usually an initial or early manifestation of active lupus disease; thrombophlebitis was recurrent in two, and pulmonary embolism was proved in two patients. Arterial occlusion developed in 7 patients, early in the course of active SLE and mainly affecting peripheral arteries in 4, later and affecting coronary arteries in three. In two patients, both arterial and venous manifestations occurred simultaneously or successively. A circulating anticoagulant with antiprothrombinase activity was present in 8 (61 percent) of the 13 patients with thromboembolic manifestations, as compared to only 21 percent of those without such manifestations, a highly significant (p less than 0.001) difference.
在60例(56例女性,4例男性)重症系统性红斑狼疮患者中,13例出现血栓栓塞性动脉和/或静脉表现,总发生率为21.6%。8例患者发生血栓性静脉炎,主要累及下肢,通常是活动性狼疮疾病的初始或早期表现;2例血栓性静脉炎复发,2例患者证实有肺栓塞。7例患者发生动脉闭塞,在活动性系统性红斑狼疮病程早期出现,4例主要累及外周动脉,3例较晚出现且累及冠状动脉。2例患者同时或先后出现动脉和静脉表现。13例有血栓栓塞表现的患者中,8例(61%)存在具有抗凝血酶原酶活性的循环抗凝物质,而无此类表现的患者中仅有21%存在该物质,差异具有高度显著性(p<0.001)。